KOLMAR BNH Co.,Ltd. (200130.KQ)
- Previous Close
14,120.00 - Open
14,160.00 - Bid 14,030.00 x --
- Ask 14,040.00 x --
- Day's Range
14,000.00 - 14,260.00 - 52 Week Range
11,030.00 - 19,970.00 - Volume
83,281 - Avg. Volume
218,381 - Market Cap (intraday)
399.245B - Beta (5Y Monthly) 0.76
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date May 15, 2025 - May 19, 2025
- Forward Dividend & Yield 308.00 (2.18%)
- Ex-Dividend Date Mar 26, 2025
- 1y Target Est
--
Kolmar BNH Co., Ltd. engages in the research and development of materials used in the functional health food and cosmetics market in South Korea and internationally. The company offers cosmetics; and provides total functional health food original development manufacturing services, such as manufacturing tablets, hard capsules, soft capsules, liquids, gels, powder dosage, and various new formulation forms. It offers packaging products, such as PTP/multi-PTP, powder stick/pouch, three-side cloth, four-side, and liquid stick packaging; and ODM consulting services. The company was formerly known as Sun Bio Tech and changed its name to Kolmar BNH Co., Ltd. in 2013. Kolmar BNH Co., Ltd. was founded in 2004 and is headquartered in Sejong, South Korea.
www.kolmarbnh.co.kr--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 200130.KQ
View MorePerformance Overview: 200130.KQ
Trailing total returns as of 5/15/2025, which may include dividends or other distributions. Benchmark is KOSPI Composite Index (^KS11) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 200130.KQ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 200130.KQ
View MoreValuation Measures
Market Cap
401.81B
Enterprise Value
516.04B
Trailing P/E
22.74
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.67
Price/Book (mrq)
1.01
Enterprise Value/Revenue
0.84
Enterprise Value/EBITDA
10.04
Financial Highlights
Profitability and Income Statement
Profit Margin
2.93%
Return on Assets (ttm)
2.22%
Return on Equity (ttm)
4.35%
Revenue (ttm)
615.64B
Net Income Avi to Common (ttm)
18.05B
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
110.65B
Total Debt/Equity (mrq)
56.89%
Levered Free Cash Flow (ttm)
-12.96B